Vikas Lifecare Intrinsic Value
Vikas Lifecare (VIKASLIFE) median intrinsic value is ₹3.77 from 2 valuation models (range ₹3–₹4), vs current price ₹1.51 — +149.7% upside (Trading Below Calculated Value), margin of safety 59.9%. Browse VIKASLIFE income statement for revenue, profit, balance sheet and cash flow data.
VIKASLIFE Valuation Methods Summary — DCF, Graham Number & P/E
Vikas Lifecare intrinsic value across 2 models vs current price ₹1.51 — upside/downside and value range per method. For current market price and key ratios, visit Vikas Lifecare share price screener.
| Method | Type | Intrinsic Value | Range | Upside/Downside | Details |
|---|---|---|---|---|---|
| Book Value Method | asset | ₹3.77 | ₹3.39 - ₹4.15 | +149.7% | Book Value/Share: ₹28.66, P/B: 1.0x |
| Revenue Multiple Method | revenue | ₹3.02 | ₹2.72 - ₹3.32 | +100.0% | Revenue/Share: ₹30.54, P/S: 0.8x |
VIKASLIFE Intrinsic Value vs Market Price — All Valuation Models
Vikas Lifecare fair value range ₹3–₹4 vs current market price ₹1.51 across 2 valuation models. Also explore VIKASLIFE share price data to track price trends across different timeframes.
VIKASLIFE Intrinsic Value Analysis — Undervalued or Overvalued?
Vikas Lifecare median intrinsic value ₹3.77, current price ₹1.51 — Trading Below Calculated Value by 149.7%, margin of safety 59.9%.
What is the intrinsic value of VIKASLIFE?
Based on our comprehensive analysis using 2 different valuation methods, the estimated intrinsic value of Vikas Lifecare (VIKASLIFE) is ₹3.77 (median value). With the current market price of ₹1.51, this represents a +149.7% variance from our estimated fair value.
The valuation range spans from ₹3.02 to ₹3.77, indicating ₹3.02 - ₹3.77.
Is VIKASLIFE undervalued or overvalued?
Based on our multi-method analysis, Vikas Lifecare (VIKASLIFE) appears to be trading below calculated value by approximately 149.7%.
VIKASLIFE Financial Health — Key Ratios vs Industry Benchmarks
Vikas Lifecare financial ratios — ROE, debt-to-equity, profit margins and liquidity vs industry benchmarks and their impact on intrinsic value.
| Financial Metric | Current Value | Industry Benchmark | Assessment | Impact on Valuation |
|---|---|---|---|---|
| Current Ratio | 6.28 | Industry Standard: 2.0+ | Above 2.0 | Measures short-term liquidity capacity |
| Return on Equity | -89.3% | Industry Standard: 15%+ | Below 10% | Measures shareholder return efficiency |
| Operating Margin | -83.0% | Industry Standard: 20%+ | Below 10% | Indicates operational efficiency level |
| Asset Turnover Ratio | 0.78x | Industry Standard: 1.0x+ | Above 0.5x | Measures asset utilization efficiency |
VIKASLIFE Cash Flow Quality — Operating & Free Cash Flow
Vikas Lifecare operating cash flow, free cash flow, quality rating and sustainability score by period — key inputs to DCF intrinsic value calculation.
| Period | Operating Cash Flow | Free Cash Flow | Cash Flow Quality | Sustainability Score |
|---|---|---|---|---|
| March 2025 | ₹-222 Cr | ₹-222 Cr | Negative Cash Flow | 3/10 |
| March 2024 | ₹-42 Cr | ₹-88 Cr | Negative Cash Flow | 3/10 |
| March 2023 | ₹-112 Cr | ₹-131 Cr | Negative Cash Flow | 3/10 |
| March 2022 | ₹-15 Cr | ₹-34 Cr | Negative Cash Flow | 3/10 |
| March 2021 | ₹-8 Cr | ₹-8 Cr | Negative Cash Flow | 3/10 |